» Articles » PMID: 28442900

Identification of Subtypes in Subjects with Mild-to-moderate Airflow Limitation and Its Clinical and Socioeconomic Implications

Overview
Publisher Dove Medical Press
Specialty Pulmonary Medicine
Date 2017 Apr 27
PMID 28442900
Citations 6
Authors
Affiliations
Soon will be listed here.
Abstract

Purpose: The purpose of this study was to identify subtypes in patients with mild-to-moderate airflow limitation and to appreciate their clinical and socioeconomic implications.

Methods: Subjects who were aged ≥20 years and had forced expiratory volume in 1 second (FEV) ≥60% predicted and FEV/forced vital capacity <0.7 were selected from the fourth Korea National Health and Nutrition Examination Survey (KNHANES) in 2007-2012. The data were merged to the National Health Insurance reimbursement database during the same period. k-Means clustering was performed to explore subtypes. For clustering analysis, six key input variables - age, body mass index (BMI), FEV% predicted, the presence or absence of self-reported wheezing, smoking status, and pack-years of smoking - were selected.

Results: Among a total of 2,140 subjects, five groups were identified through k-means clustering, namely putative "near-normal (n=232)," "asthmatic (n=392)," "chronic obstructive pulmonary disease (COPD) (n=37)," "asthmatic-overlap (n=893)," and "COPD-overlap (n=586)" subtypes. Near-normal group showed the oldest mean age (72±7 years) and highest FEV (102%±8% predicted), and asthmatic group was the youngest (46±9 years). COPD and COPD-overlap groups were male predominant and all current or ex-smokers. While asthmatic group had the lowest prescription rate despite the highest proportion of self-reported wheezing, COPD, asthmatic-overlap, and COPD-overlap groups showed high prescription rate of respiratory medicine. Although COPD group formed only 1.7% of total subjects, they showed the highest mean medical cost and health care utilization, comprising 5.3% of the total medical cost. When calculating a ratio of total medical expense to household income, the mean ratio was highest in the COPD group.

Conclusion: Clinical and epidemiological heterogeneities of subjects with mild-to-moderate airflow limitation and a different level of health care utilization by each subtype are shown. Identification of a subtype with high health care demand could be a priority for effective utilization of limited resources.

Citing Articles

Status of Studies Investigating Asthma-Chronic Obstructive Pulmonary Disease Overlap in Korea: A Review.

Jo Y Tuberc Respir Dis (Seoul). 2021; 85(2):101-110.

PMID: 34871477 PMC: 8987665. DOI: 10.4046/trd.2021.0140.


A Systematic Review of Asthma Phenotypes Derived by Data-Driven Methods.

Cunha F, Amaral R, Jacinto T, Sousa-Pinto B, Fonseca J Diagnostics (Basel). 2021; 11(4).

PMID: 33918233 PMC: 8066118. DOI: 10.3390/diagnostics11040644.


Simulation-derived best practices for clustering clinical data.

Coombes C, Liu X, Abrams Z, Coombes K, Brock G J Biomed Inform. 2021; 118:103788.

PMID: 33862229 PMC: 9017600. DOI: 10.1016/j.jbi.2021.103788.


Unsupervised machine learning and prognostic factors of survival in chronic lymphocytic leukemia.

Coombes C, Abrams Z, Li S, Abruzzo L, Coombes K J Am Med Inform Assoc. 2020; 27(7):1019-1027.

PMID: 32483590 PMC: 7647286. DOI: 10.1093/jamia/ocaa060.


Clinical profile of predefined asthma phenotypes in a large cohort of UK primary care patients (Clinical Practice Research Datalink).

Nissen F, Douglas I, Mullerova H, Pearce N, Bloom C, Smeeth L J Asthma Allergy. 2019; 12:7-19.

PMID: 30662273 PMC: 6329349. DOI: 10.2147/JAA.S182013.


References
1.
Rabin R, de Charro F . EQ-5D: a measure of health status from the EuroQol Group. Ann Med. 2001; 33(5):337-43. DOI: 10.3109/07853890109002087. View

2.
Guirguis-Blake J, Senger C, Webber E, Mularski R, Whitlock E . Screening for Chronic Obstructive Pulmonary Disease: Evidence Report and Systematic Review for the US Preventive Services Task Force. JAMA. 2016; 315(13):1378-93. DOI: 10.1001/jama.2016.2654. View

3.
Siu A, Bibbins-Domingo K, C Grossman D, Davidson K, Epling Jr J, Garcia F . Screening for Chronic Obstructive Pulmonary Disease: US Preventive Services Task Force Recommendation Statement. JAMA. 2016; 315(13):1372-7. DOI: 10.1001/jama.2016.2638. View

4.
Hwang Y, Kim C, Kang H, Shin T, Park S, Jang S . Comparison of the prevalence of chronic obstructive pulmonary disease diagnosed by lower limit of normal and fixed ratio criteria. J Korean Med Sci. 2009; 24(4):621-6. PMC: 2719218. DOI: 10.3346/jkms.2009.24.4.621. View

5.
Regan E, Lynch D, Curran-Everett D, Curtis J, Austin J, Grenier P . Clinical and Radiologic Disease in Smokers With Normal Spirometry. JAMA Intern Med. 2015; 175(9):1539-49. PMC: 4564354. DOI: 10.1001/jamainternmed.2015.2735. View